Allison Zhang, DO
Gastroenterology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Zhang’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A165178 · Current
Licensed to practise in California · since 2019 · expires 2027-09-30 · Wayne State University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$104,574
Medicare paid this office $104,574 for 390 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 131 | $30,522 | $231 |
| New patient visit (45+ min) | 154 | $20,497 | $133 |
| Return visit (30+ min) | 110 | $13,928 | $111 |
| Long return visit (40+ min) | 57 | $10,448 | $156 |
| New patient visit (60+ min) | 43 | $8,262 | $192 |
See all 8 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 131 | $30,522 | $231 |
| New patient visit (45+ min) | 154 | $20,497 | $133 |
| Return visit (30+ min) | 110 | $13,928 | $111 |
| Long return visit (40+ min) | 57 | $10,448 | $156 |
| New patient visit (60+ min) | 43 | $8,262 | $192 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 80 | $6,503 | $78 |
| Biopsy of large bowel using a flexible endoscope | 124 | $4,400 | $35 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 182 | $2,973 | $15 |
Procedures Medicare counted
| Colonoscopy | 124 | More than 84% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 90 | More than 74% of doctors who do this |
Who their Medicare patients are
390 Original Medicare patients in 2024. Average age 72 · Under 65 7% · 85 and older 6% · Women 65% · Also on Medicaid 14% · Health risk score 1.08. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 69% · Diabetes 33% · Coronary heart disease 24% · Depression 20% · Chronic kidney disease 18% · Cancer 18% · Atrial fibrillation 16% · Heart failure 12% · COPD 9% · Stroke 6% · Dementia 3%.
The office billed $1,063,437, Medicare allowed $138,957 and paid $104,574; for 993 services of 23 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 390 | 993 | 72 | 1.08 | $1,063,437 | $104,574 |
| 2023 | 288 | 582 | 72 | 1.05 | $645,062 | $72,958 |
| 2022 | 222 | 379 | 72 | 1.09 | $419,509 | $52,255 |
| 2021 | 262 | 543 | 73 | 0.96 | $686,477 | $80,205 |
| 2020 | 79 | 167 | 74 | 1.05 | $166,113 | $22,231 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 77 | $17,518 | $225 |
| New patient visit (45+ min) | 120 | $16,895 | $141 |
| New patient visit (60+ min) | 50 | $10,090 | $202 |
| Return visit (30+ min) | 67 | $7,950 | $110 |
| Long return visit (40+ min) | 38 | $7,317 | $166 |
| Biopsy of large bowel using a flexible endoscope | 65 | $3,723 | $56 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 42 | $3,167 | $75 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 11 | $1,752 | $159 |
| Telehealth originating site facility fee | 65 | $1,529 | $22 |
2022: 7 services
| New patient visit (45+ min) | 88 | $12,591 | $143 |
| New patient visit (60+ min) | 50 | $10,678 | $214 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 40 | $8,245 | $201 |
| Long return visit (40+ min) | 35 | $6,121 | $157 |
| Return visit (30+ min) | 43 | $5,225 | $114 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 46 | $3,896 | $85 |
| Biopsy of large bowel using a flexible endoscope | 40 | $2,798 | $68 |
2021: 7 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 69 | $15,903 | $230 |
| New patient visit (45+ min) | 96 | $15,769 | $164 |
| Long return visit (40+ min) | 71 | $14,457 | $176 |
| New patient visit (60+ min) | 45 | $10,210 | $227 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 81 | $7,224 | $84 |
| Biopsy of large bowel using a flexible endoscope | 82 | $6,719 | $81 |
| Return visit (30+ min) | 35 | $4,693 | $124 |
2020: 5 services
| Long return visit (40+ min) | 29 | $5,295 | $156 |
| Return visit (30+ min) | 22 | $3,674 | $108 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $2,868 | $239 |
| Biopsy of large bowel using a flexible endoscope | 16 | $1,802 | $113 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,697 | $94 |
Drugs they prescribed that Part D paid
$22,615
Pharmacies billed $22,615 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 466) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
387 generic and 79 brand-name prescriptions · $22,615 in drug cost · 24 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Esomeprazole Magnesium | 18 | $2,773 | $154 |
| Sod Sulf-Potass Sulf-Mag Sulf | 39 | $2,589 | $66 |
| Gavilyte-G | 152 | $2,210 | $15 |
| Omeprazole | 90 | $1,575 | $18 |
| Peg-3350 and Electrolytes | 50 | $948 | $19 |
See all 7 drugs
| Esomeprazole Magnesium | 18 | $2,773 | $154 |
| Sod Sulf-Potass Sulf-Mag Sulf | 39 | $2,589 | $66 |
| Gavilyte-G | 152 | $2,210 | $15 |
| Omeprazole | 90 | $1,575 | $18 |
| Peg-3350 and Electrolytes | 50 | $948 | $19 |
| Pantoprazole | 26 | $292 | $11 |
| Metronidazole | 12 | $118 | $10 |
Year by year
| 2024 | 466 | 293 | 0% (0) | 17% | $22,615 |
| 2023 | 404 | 245 | 0% (0) | 8% | $48,874 |
| 2022 | 264 | 150 | 0% (0) | 12% | $17,964 |
| 2021 | 482 | 210 | 0% (0) | 26% | $26,750 |
| 2020 | 138 | 71 | 0% (0) | 28% | $6,573 |
| 2019 | 32 | 19 | 0% (0) | None | $1,161 |
| 2018 | 51 | 15 | 0% (0) | None | $1,934 |
| 2017 | 28 | None | 0% (0) | None | $973 |
| 2016 | 376 | 42 | 4% (13) | None | $34,260 |
| 2015 | 255 | 50 | 5% (12) | 23% | $37,101 |
| 2014 | 169 | 35 | None | None | $13,317 |
| 2013 | 25 | None | None | None | $1,920 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Esomeprazole Magnesium | 21 | $3,011 | $143 |
| Gavilyte-G | 166 | $2,974 | $18 |
| Omeprazole | 76 | $1,243 | $16 |
| Pantoprazole | 19 | $445 | $23 |
| Tenofovir Disoproxil | 12 | $287 | $24 |
| Peg-3350 and Electrolytes | 12 | $211 | $18 |
| Famotidine | 15 | $95 | $6 |
2022: 5 drugs
| Omeprazole | 73 | $1,459 | $20 |
| Esomeprazole Magnesium | 19 | $1,184 | $62 |
| Gavilyte-C | 28 | $467 | $17 |
| Gavilyte-G | 26 | $425 | $16 |
| Pantoprazole | 27 | $363 | $13 |
2021: 9 drugs
| Suprep | 72 | $7,832 | $109 |
| Linzess | 11 | $5,786 | $526 |
| Sutab | 27 | $4,048 | $150 |
| Pantoprazole | 150 | $1,632 | $11 |
| Omeprazole | 75 | $1,341 | $18 |
| Esomeprazole Magnesium | 20 | $1,299 | $65 |
| Tenofovir Disoproxil | 12 | $632 | $53 |
| Gavilyte-C | 28 | $394 | $14 |
| Metronidazole | 11 | $133 | $12 |
2020: 3 drugs
| Suprep | 33 | $3,408 | $103 |
| Pantoprazole | 51 | $741 | $15 |
| Gavilyte-G | 12 | $180 | $15 |
2016: 11 drugs
| Spiriva | 15 | $4,950 | $330 |
| Atorvastatin | 24 | $411 | $17 |
| Omeprazole | 22 | $177 | $8 |
| Levothyroxine | 14 | $121 | $9 |
| Simvastatin | 22 | $109 | $5 |
| Amlodipine Besylate | 27 | $98 | $4 |
| Carvedilol | 11 | $96 | $9 |
| Lisinopril | 19 | $62 | $3 |
| Losartan | 11 | $52 | $5 |
| Metformin | 11 | $34 | $3 |
| Hydrochlorothiazide | 12 | $18 | $1 |
2015: 7 drugs
| Chlorthalidone | 13 | $746 | $57 |
| Atorvastatin | 17 | $165 | $10 |
| Amlodipine Besylate | 20 | $104 | $5 |
| Omeprazole | 11 | $88 | $8 |
| Lisinopril | 19 | $80 | $4 |
| Metoprolol | 15 | $65 | $4 |
| Simvastatin | 12 | $41 | $3 |
2014: 1 drug
| Lisinopril | 18 | $113 | $6 |
Money from drug and device companies
$23 in 2025
A payment is not proof that care is biased.
| Braintree Laboratories | Suflave | $23 | 1 payment
|
See the published payment
| Braintree Laboratories | Meals · 2025-05-23 | Suflave | $23 |
Professional record
- NPI
- 1821435900
- Licence
- CA A165178California A165178: Current · expires 2027-09-30
- Trained
- Wayne State University School of Medicine, 2013
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X)
- Mailing address
- 2585 Samaritan Dr Ste 25 2nd Fl, San Jose, CA, 95124
- NPI first listed
- 2013-05-29
- NPI last updated
- 2024-04-12
- NPI record certified
- 2024-04-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 14777 Los Gatos Blvd Ste 200, Los Gatos, CA, 95032